Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Atypical diabetes

Neonatal diabetes

30-10-2018 | Monogenic diabetes | Review | Article

Genetics of monogenic diabetes: Present clinical challenges

Misra S, Owen KR. Curr Diab Rep 2018; 18: 141. doi: 10.1007/s11892-018-1111-4

09-08-2018 | Neonatal diabetes | Case report | Article

Successful treatment of diabetic ketoacidosis and hyperglycemic hyperosmolar status in an infant with KCNJ11-related neonatal diabetes mellitus via continuous renal replacement therapy

Chen T et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0484-3

13-06-2018 | Neonatal diabetes | Review | Article

Congenital diabetes: Comprehensive genetic testing allows for improved diagnosis and treatment of diabetes and other associated features

Letourneau LR, Greeley SAW. Curr Diab Rep 2018; 18: 46. doi: 10.1007/s11892-018-1016-2

05-06-2018 | Neonatal diabetes | Highlight | News

Reassuring long-term data for sulfonylurea in neonatal diabetes

Sulfonylurea treatment is durably effective with a low rate of side effects in patients with permanent neonatal diabetes caused by mutations in the KCNJ11 gene, a study in The Lancet Diabetes & Endocrinology shows.

04-06-2018 | Neonatal diabetes | Article

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: An international cohort study

Bowman P et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30106-2

18-05-2018 | Gestational diabetes | Review | Article

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes

Yeung RO et al. Rev Endocr Metab Disord 2018. doi: 10.1007/s11154-018-9446-3

07-10-2017 | Neonatal diabetes | Case report | Article

Neonatal diabetes in a patient with IPEX syndrome: An attempt at balancing insulin therapy

Romano F et al. Acta Diabetol 2017; 54: 1139. doi: 10.1007/s00592-017-1057-z

22-08-2017 | Neonatal diabetes | News

Dried blood spot screening shows promise for neonatal diabetes

Neonatal diabetes could be detected as early as day 5 of life using glucose measurements from dried blood spots, researchers report.

05-08-2017 | Neonatal diabetes | Article

Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement

McDonald TJ et al. Diabetologia 2017; 60: 2168–2173. doi: 10.1007/s00125-017-4383-3

09-02-2017 | Ketoacidosis | News

Neonatal diabetes complications can have profound impact

Researchers report two cases of children with severe and irreversible neurologic damage caused by complications at the time of neonatal diabetes diagnosis, highlighting the need for increased awareness of the condition.

26-04-2016 | Neonatal diabetes | Case report | Article

Not all diabetes in infants is type 1: A case report

Arce, KM, Pantalone KM. Diabetes Ther 2016; 7: 369. doi: 10.1007/s13300-016-0171-1


More on atypical diabetes

« Back to main page | Diagnosis | Drug-induced diabetes | Latent autoimmune diabetes of adulthood | Maturity-onset diabetes of the young | Monogenic diabetes | Neonatal diabetes


Image Credits